Global Brain Aneurysm Treatment

Brain Aneurysm Treatment Comprehensive Study by Type (Surgical Clipping, Endovascular Coiling, Flow diverters), Application (Hospitals, Clinics), Type (Unruptured Aneurysm, Ruptured Aneurysm) Players and Region - Global Market Outlook to 2030

Brain Aneurysm Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Brain Aneurysm Treatment Market Scope
Aneurysms can be caused by a number of factors, including high blood pressure and atherosclerosis, trauma, genetics, and irregular blood flow at the point where two arteries meet. Aneurysm treatment is surgery that corrects an aneurysm in the brain. This is a weak spot in the wall of a blood artery that causes it to expand or inflate out and occasionally explode (rupture). It would cause bleeding into the cerebrospinal fluid (CSF) surrounding the brain.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD N)
Key Companies ProfiledStryker Corporation (United States), Penumbra, Inc (United States), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Mizuho Medical Co, Ltd (Japan), Penumbra, Inc (United States), Spiegelberg GmbH (Germany), Medtronic (Ireland), Johnson & Johnson Services, Inc (United States) and Kaneka Corporation (Japan)
CAGR%


Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Brain Aneurysm Treatment market throughout the predicted period.

Stryker Corporation (United States), Penumbra, Inc (United States), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Mizuho Medical Co, Ltd (Japan), Penumbra, Inc (United States), Spiegelberg GmbH (Germany), Medtronic (Ireland), Johnson & Johnson Services, Inc (United States) and Kaneka Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Raumedic AG (Germany), Adeor medical AG (Germany) and Evasc Medical Systems Corp (Canada).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Brain Aneurysm Treatment market by Type , by Application (Hospitals and Clinics) and Region with country level break-up.

On the basis of geography, the market of Brain Aneurysm Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In June 2020, Rapid AI acquires Endo Vantage to expand the scope and include Aneurysm, extending its leadership in Cerebrovascular Imaging. Rapid AI range of applications continues to grow, from ischemic stroke to hemorrhagic stroke and now aneurysm. The acquisition will help the firm will be able to focus on aneurysms. Endo Vantage is a strong award-winning computational platform that enables complete cerebral aneurysm care, automating the whole process from initial evaluation through growth tracking to treatment planning. It uses CTA and MRA images to provide findings that assist clinicians in locating and tracking aneurysm growth, as well as data from 3D rotational angiograms to provide comprehensive 3D models of a patient's vasculature and allow presurgical planning for aneurysm treatment.
In August 2020, Stryker launches its Surpass Evolve Diverter and U.S FDA approval on it. The company says that it's the first 64-wire cobalt-chromium flow diverter in the United States, and it's meant to help aneurysms repair. The service expands on Stryker's Surpass Streamline and is the first physician to finish a commercial case in the United States. The new 64-wire device provides good flow diversion and a very flexible implant for improved vessel wall contact by increasing the braid angle. Surpass Evolve has a greater mesh density than standard 48-wire flow diverters, which may result in quicker aneurysm closure for patients.
“As per USFDA cerebral aneurysm is a weak or thin area on a blood artery in the brain that fills with blood and expands out. Nerves, meninges, and/or surrounding brain tissue may be compressed by a bulging aneurysm. It may also burst or leak, causing blood to flow into the surrounding tissue. Some aneurysms in the brain, especially those that are tiny, may never bleed or produce clinical consequences. The majority of aneurysm treatments are done on non-ruptured aneurysms. Unruptured aneurysms are treated to reduce the chance of rupture, which can lead to a subarachnoid hemorrhage (SAH). Because subarachnoid hemorrhage can cause death and significant morbidity, it is treated prophylactically. Ruptured aneurysms are also routinely treated since untreated ruptured aneurysms have a significant risk of recurrent SAH.”

Influencing Trend:
Introducing new Technologies and Medical Devices for the Treatment and Adoption of Surgical Robot for the Treatment of Brain Aneurysm

Market Growth Drivers:
Rising Prevalence of Brain Aneurysm and Associated Risk Factor and Rise in Number of Research and Development Activities for the Treatment

Challenges:
Risk of Potentially Serious Complication such as Brain Damage and Stroke can hinder the Brain Aneurysm Treatment Market

Restraints:
High Cost of Surgical Procedure can hamper the Market

Opportunities:
Increasing the Financial Aid to Boot the Innovation will grow the Brain Aneurysm Treatment Market

Key Target Audience
Brain Aneurysm Treatment Hospitals & Clinics, Research and Development Institutes, Financial Institutes and Investors, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Surgical Clipping
  • Endovascular Coiling
  • Flow diverters
By Application
  • Hospitals
  • Clinics
By Type
  • Unruptured Aneurysm
  • Ruptured Aneurysm

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Brain Aneurysm and Associated Risk Factor
      • 3.2.2. Rise in Number of Research and Development Activities for the Treatment
    • 3.3. Market Challenges
      • 3.3.1. Risk of Potentially Serious Complication such as Brain Damage and Stroke can hinder the Brain Aneurysm Treatment Market
    • 3.4. Market Trends
      • 3.4.1. Introducing new Technologies and Medical Devices for the Treatment
      • 3.4.2. Adoption of Surgical Robot for the Treatment of Brain Aneurysm
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Brain Aneurysm Treatment, by Type, Application, Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Brain Aneurysm Treatment (Value)
      • 5.2.1. Global Brain Aneurysm Treatment by: Type (Value)
        • 5.2.1.1. Surgical Clipping
        • 5.2.1.2. Endovascular Coiling
        • 5.2.1.3. Flow diverters
      • 5.2.2. Global Brain Aneurysm Treatment by: Type (Value)
        • 5.2.2.1. Unruptured Aneurysm
        • 5.2.2.2. Ruptured Aneurysm
      • 5.2.3. Global Brain Aneurysm Treatment by: Application (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
      • 5.2.4. Global Brain Aneurysm Treatment by: Type (Value)
        • 5.2.4.1. Surgical Clipping
        • 5.2.4.2. Endovascular Coiling
        • 5.2.4.3. Flow diverters
      • 5.2.5. Global Brain Aneurysm Treatment by: Type (Value)
        • 5.2.5.1. Unruptured Aneurysm
        • 5.2.5.2. Ruptured Aneurysm
      • 5.2.6. Global Brain Aneurysm Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Brain Aneurysm Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Stryker Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Penumbra, Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. MicroPort Scientific Corporation (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Terumo Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mizuho Medical Co, Ltd (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Penumbra, Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Spiegelberg GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Johnson & Johnson Services, Inc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kaneka Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Brain Aneurysm Treatment Sale, by Type, Application, Type and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Brain Aneurysm Treatment (Value)
      • 7.2.1. Global Brain Aneurysm Treatment by: Type (Value)
        • 7.2.1.1. Surgical Clipping
        • 7.2.1.2. Endovascular Coiling
        • 7.2.1.3. Flow diverters
      • 7.2.2. Global Brain Aneurysm Treatment by: Type (Value)
        • 7.2.2.1. Unruptured Aneurysm
        • 7.2.2.2. Ruptured Aneurysm
      • 7.2.3. Global Brain Aneurysm Treatment by: Application (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
      • 7.2.4. Global Brain Aneurysm Treatment by: Type (Value)
        • 7.2.4.1. Surgical Clipping
        • 7.2.4.2. Endovascular Coiling
        • 7.2.4.3. Flow diverters
      • 7.2.5. Global Brain Aneurysm Treatment by: Type (Value)
        • 7.2.5.1. Unruptured Aneurysm
        • 7.2.5.2. Ruptured Aneurysm
      • 7.2.6. Global Brain Aneurysm Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Brain Aneurysm Treatment: by Type(USD N)
  • Table 2. Brain Aneurysm Treatment Surgical Clipping , by Region USD N (2018-2023)
  • Table 3. Brain Aneurysm Treatment Endovascular Coiling , by Region USD N (2018-2023)
  • Table 4. Brain Aneurysm Treatment Flow diverters , by Region USD N (2018-2023)
  • Table 5. Brain Aneurysm Treatment: by Type(USD N)
  • Table 6. Brain Aneurysm Treatment Unruptured Aneurysm , by Region USD N (2018-2023)
  • Table 7. Brain Aneurysm Treatment Ruptured Aneurysm , by Region USD N (2018-2023)
  • Table 8. Brain Aneurysm Treatment: by Application(USD N)
  • Table 9. Brain Aneurysm Treatment Hospitals , by Region USD N (2018-2023)
  • Table 10. Brain Aneurysm Treatment Clinics , by Region USD N (2018-2023)
  • Table 11. Brain Aneurysm Treatment: by Type(USD N)
  • Table 12. Brain Aneurysm Treatment Surgical Clipping , by Region USD N (2018-2023)
  • Table 13. Brain Aneurysm Treatment Endovascular Coiling , by Region USD N (2018-2023)
  • Table 14. Brain Aneurysm Treatment Flow diverters , by Region USD N (2018-2023)
  • Table 15. Brain Aneurysm Treatment: by Type(USD N)
  • Table 16. Brain Aneurysm Treatment Unruptured Aneurysm , by Region USD N (2018-2023)
  • Table 17. Brain Aneurysm Treatment Ruptured Aneurysm , by Region USD N (2018-2023)
  • Table 18. South America Brain Aneurysm Treatment, by Country USD N (2018-2023)
  • Table 19. South America Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 20. South America Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 21. South America Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 22. Brazil Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 23. Brazil Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 24. Brazil Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 25. Argentina Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 26. Argentina Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 27. Argentina Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 28. Rest of South America Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 29. Rest of South America Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 30. Rest of South America Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 31. Asia Pacific Brain Aneurysm Treatment, by Country USD N (2018-2023)
  • Table 32. Asia Pacific Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 33. Asia Pacific Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 34. Asia Pacific Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 35. China Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 36. China Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 37. China Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 38. Japan Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 39. Japan Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 40. Japan Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 41. India Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 42. India Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 43. India Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 44. South Korea Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 45. South Korea Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 46. South Korea Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 47. Taiwan Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 48. Taiwan Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 49. Taiwan Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 50. Australia Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 51. Australia Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 52. Australia Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 53. Rest of Asia-Pacific Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 54. Rest of Asia-Pacific Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 55. Rest of Asia-Pacific Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 56. Europe Brain Aneurysm Treatment, by Country USD N (2018-2023)
  • Table 57. Europe Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 58. Europe Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 59. Europe Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 60. Germany Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 61. Germany Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 62. Germany Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 63. France Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 64. France Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 65. France Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 66. Italy Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 67. Italy Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 68. Italy Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 69. United Kingdom Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 70. United Kingdom Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 71. United Kingdom Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 72. Netherlands Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 73. Netherlands Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 74. Netherlands Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 75. Rest of Europe Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 76. Rest of Europe Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 77. Rest of Europe Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 78. MEA Brain Aneurysm Treatment, by Country USD N (2018-2023)
  • Table 79. MEA Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 80. MEA Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 81. MEA Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 82. Middle East Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 83. Middle East Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 84. Middle East Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 85. Africa Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 86. Africa Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 87. Africa Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 88. North America Brain Aneurysm Treatment, by Country USD N (2018-2023)
  • Table 89. North America Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 90. North America Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 91. North America Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 92. United States Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 93. United States Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 94. United States Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 95. Canada Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 96. Canada Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 97. Canada Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 98. Mexico Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 99. Mexico Brain Aneurysm Treatment, by Application USD N (2018-2023)
  • Table 100. Mexico Brain Aneurysm Treatment, by Type USD N (2018-2023)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Brain Aneurysm Treatment: by Type(USD N)
  • Table 112. Brain Aneurysm Treatment Surgical Clipping , by Region USD N (2025-2030)
  • Table 113. Brain Aneurysm Treatment Endovascular Coiling , by Region USD N (2025-2030)
  • Table 114. Brain Aneurysm Treatment Flow diverters , by Region USD N (2025-2030)
  • Table 115. Brain Aneurysm Treatment: by Type(USD N)
  • Table 116. Brain Aneurysm Treatment Unruptured Aneurysm , by Region USD N (2025-2030)
  • Table 117. Brain Aneurysm Treatment Ruptured Aneurysm , by Region USD N (2025-2030)
  • Table 118. Brain Aneurysm Treatment: by Application(USD N)
  • Table 119. Brain Aneurysm Treatment Hospitals , by Region USD N (2025-2030)
  • Table 120. Brain Aneurysm Treatment Clinics , by Region USD N (2025-2030)
  • Table 121. Brain Aneurysm Treatment: by Type(USD N)
  • Table 122. Brain Aneurysm Treatment Surgical Clipping , by Region USD N (2025-2030)
  • Table 123. Brain Aneurysm Treatment Endovascular Coiling , by Region USD N (2025-2030)
  • Table 124. Brain Aneurysm Treatment Flow diverters , by Region USD N (2025-2030)
  • Table 125. Brain Aneurysm Treatment: by Type(USD N)
  • Table 126. Brain Aneurysm Treatment Unruptured Aneurysm , by Region USD N (2025-2030)
  • Table 127. Brain Aneurysm Treatment Ruptured Aneurysm , by Region USD N (2025-2030)
  • Table 128. South America Brain Aneurysm Treatment, by Country USD N (2025-2030)
  • Table 129. South America Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 130. South America Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 131. South America Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 132. Brazil Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 133. Brazil Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 134. Brazil Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 135. Argentina Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 136. Argentina Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 137. Argentina Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 138. Rest of South America Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 139. Rest of South America Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 140. Rest of South America Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 141. Asia Pacific Brain Aneurysm Treatment, by Country USD N (2025-2030)
  • Table 142. Asia Pacific Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 143. Asia Pacific Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 144. Asia Pacific Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 145. China Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 146. China Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 147. China Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 148. Japan Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 149. Japan Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 150. Japan Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 151. India Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 152. India Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 153. India Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 154. South Korea Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 155. South Korea Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 156. South Korea Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 157. Taiwan Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 158. Taiwan Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 159. Taiwan Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 160. Australia Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 161. Australia Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 162. Australia Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 163. Rest of Asia-Pacific Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 164. Rest of Asia-Pacific Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 165. Rest of Asia-Pacific Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 166. Europe Brain Aneurysm Treatment, by Country USD N (2025-2030)
  • Table 167. Europe Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 168. Europe Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 169. Europe Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 170. Germany Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 171. Germany Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 172. Germany Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 173. France Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 174. France Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 175. France Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 176. Italy Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 177. Italy Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 178. Italy Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 179. United Kingdom Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 180. United Kingdom Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 181. United Kingdom Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 182. Netherlands Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 183. Netherlands Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 184. Netherlands Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 185. Rest of Europe Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 186. Rest of Europe Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 187. Rest of Europe Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 188. MEA Brain Aneurysm Treatment, by Country USD N (2025-2030)
  • Table 189. MEA Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 190. MEA Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 191. MEA Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 192. Middle East Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 193. Middle East Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 194. Middle East Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 195. Africa Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 196. Africa Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 197. Africa Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 198. North America Brain Aneurysm Treatment, by Country USD N (2025-2030)
  • Table 199. North America Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 200. North America Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 201. North America Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 202. United States Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 203. United States Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 204. United States Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 205. Canada Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 206. Canada Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 207. Canada Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 208. Mexico Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 209. Mexico Brain Aneurysm Treatment, by Application USD N (2025-2030)
  • Table 210. Mexico Brain Aneurysm Treatment, by Type USD N (2025-2030)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Brain Aneurysm Treatment: by Type USD N (2018-2023)
  • Figure 5. Global Brain Aneurysm Treatment: by Type USD N (2018-2023)
  • Figure 6. Global Brain Aneurysm Treatment: by Application USD N (2018-2023)
  • Figure 7. Global Brain Aneurysm Treatment: by Type USD N (2018-2023)
  • Figure 8. Global Brain Aneurysm Treatment: by Type USD N (2018-2023)
  • Figure 9. South America Brain Aneurysm Treatment Share (%), by Country
  • Figure 10. Asia Pacific Brain Aneurysm Treatment Share (%), by Country
  • Figure 11. Europe Brain Aneurysm Treatment Share (%), by Country
  • Figure 12. MEA Brain Aneurysm Treatment Share (%), by Country
  • Figure 13. North America Brain Aneurysm Treatment Share (%), by Country
  • Figure 14. Global Brain Aneurysm Treatment share by Players 2023 (%)
  • Figure 15. Global Brain Aneurysm Treatment share by Players (Top 3) 2023(%)
  • Figure 16. Global Brain Aneurysm Treatment share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Stryker Corporation (United States) Revenue: by Geography 2023
  • Figure 20. Penumbra, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Penumbra, Inc (United States) Revenue: by Geography 2023
  • Figure 22. MicroPort Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 23. MicroPort Scientific Corporation (China) Revenue: by Geography 2023
  • Figure 24. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 25. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 26. Mizuho Medical Co, Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Mizuho Medical Co, Ltd (Japan) Revenue: by Geography 2023
  • Figure 28. Penumbra, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 29. Penumbra, Inc (United States) Revenue: by Geography 2023
  • Figure 30. Spiegelberg GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Spiegelberg GmbH (Germany) Revenue: by Geography 2023
  • Figure 32. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 34. Johnson & Johnson Services, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 35. Johnson & Johnson Services, Inc (United States) Revenue: by Geography 2023
  • Figure 36. Kaneka Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 37. Kaneka Corporation (Japan) Revenue: by Geography 2023
  • Figure 38. Global Brain Aneurysm Treatment: by Type USD N (2025-2030)
  • Figure 39. Global Brain Aneurysm Treatment: by Type USD N (2025-2030)
  • Figure 40. Global Brain Aneurysm Treatment: by Application USD N (2025-2030)
  • Figure 41. Global Brain Aneurysm Treatment: by Type USD N (2025-2030)
  • Figure 42. Global Brain Aneurysm Treatment: by Type USD N (2025-2030)
  • Figure 43. South America Brain Aneurysm Treatment Share (%), by Country
  • Figure 44. Asia Pacific Brain Aneurysm Treatment Share (%), by Country
  • Figure 45. Europe Brain Aneurysm Treatment Share (%), by Country
  • Figure 46. MEA Brain Aneurysm Treatment Share (%), by Country
  • Figure 47. North America Brain Aneurysm Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Stryker Corporation (United States)
  • Penumbra, Inc (United States)
  • MicroPort Scientific Corporation (China)
  • Terumo Corporation (Japan)
  • Mizuho Medical Co, Ltd (Japan)
  • Penumbra, Inc (United States)
  • Spiegelberg GmbH (Germany)
  • Medtronic (Ireland)
  • Johnson & Johnson Services, Inc (United States)
  • Kaneka Corporation (Japan)
Additional players considered in the study are as follows:
Raumedic AG (Germany) , Adeor medical AG (Germany) , Evasc Medical Systems Corp (Canada)
Select User Access Type

Key Highlights of Report


Mar 2024 214 Pages 64 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Brain Aneurysm Treatment Quantitative research analysis
Global Brain Aneurysm Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Brain Aneurysm Treatment Market are by type [Surgical Clipping, Endovascular Coiling and Flow diverters], by end use application [Hospitals and Clinics].
The Brain Aneurysm Treatment Market is gaining popularity and expected to see strong valuation by 2030.
  • Rising Prevalence of Brain Aneurysm and Associated Risk Factor
  • Rise in Number of Research and Development Activities for the Treatment

Know More About Global Brain Aneurysm Treatment Report?

Have a Query? Click Here

Other Related Reports

Membrane Filtration Systems Comprehensive Study by Type (Microfiltration (MF), Ultrafiltration (UF), Nanofiltration (NF), Reverse Osmosis (RO)), Application (Industrial Water And Wastewater Treatment...
$ 3450
Onychomycosis Comprehensive Study by Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis), Application (Children, Male Adult...
$ 3650
Sports Medicine Products Comprehensive Study by Type (Body reconstruction products, Body support & recovery products, Medical accessories), Application (Shoulder injuries, Foot and ankle injuries, El...
$ 3750
Tuberculin Comprehensive Study by Type (PPD-S, PPD RT23, Others), Application (Human Use, Animal Use), Therapy (First-Line Therapy, Second-Line Therapy) Players and Region - Global Market Outlook to ...
$ 3500
Homeopathy Comprehensive Study by Type (Tincture, Dilutions, Biochemics, Ointments, Tablets), Application (Respiratory, Neurology, Immunology, Gastroenterology, Dermatology, Others), Treatment (Auto-...
$ 3650
Medical Lab Software Comprehensive Study by Application (PC Terminal, Mobile Terminal), End users (Health Care, Medical Lab, Others), Services (MEDICAL LABORATORY MANAGEMENT, REPORTS, BILLING, TEST R...
$ 3450